Evaluation of clinical significance of TP53, BCL-2, BAX and MEKI expression in 229 ovarian carcinomas treated with platinum-based regimen
Kupryjanczyk, J, Szymanska, T, Madry, R, Timorek, A, Stelmachow, J, Karpinska, G, Rembiszewska, A, Ziolekowska, I, Kraszewska, E, Debniak, J, Emerich, J, Uleanska, M, Pleuzanska, A, Jedryka, M
Published in British journal of cancer (24.03.2003)
Published in British journal of cancer (24.03.2003)
Get full text
Journal Article